Challenges in advancing mental and physical health of patients with serious mental illness

Journal of Psychopharmacology

Volumn 19, Issue 6 SUPPL., 2005, Pages 3-5

  Dursun, Serdar ^a   Dinan, Timothy G ^b   Bushe, Chris ^c   Thakore, Jogin ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c ELI LILLY AND COMPANY   (United States)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; EDITORIAL; HEALTH PROMOTION; HEALTH STATUS; HUMAN; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA;

BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; HUMANS; LIFE STYLE; MENTAL HEALTH; METABOLIC SYNDROME X; OBESITY; PHYSICAL FITNESS; PSYCHOTROPIC DRUGS; RISK FACTORS; RISK REDUCTION BEHAVIOR; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33749995687     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105058969     Document Type: Editorial

References (12)

1. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27: 596-601
2. Brown S, Inskip H, Barraclough B (2000) Causes of the excess mortality of schizophrenia. Br J Psychiatry 177: 212-217
3. Bushe C, Leonard B (2004) Association between atypical antipsychotic agents and type 2 diabetes: review of prospective clinical data. Br J Psychiatry Suppl 47: S87-S93
4. Canadian Diabetes Association (2003) Clinical Practice Guidelines Expert Committee. CDA 2003 Clinical practice guidelines for the prevention and management of diabetes: screening and prevention. Can J Diabetes 27 (Suppl 2): S10-S33
5. Expert Consensus Meeting (2003) 'Schizophrenia and Diabetes 2003' Dublin, 3-4 October: consensus summary (2004). Br J Psychiatry 47 (Suppl): S112-S114
6. Gough S, Peveller R (2004) Diabetes and its prevention: pragmatic solutions for people with schizophrenia. Br J Psychiatry 47 (Suppl): S106-S111.
7. Lambert T J, Chapman L H (2004) Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 181: 544-548
8. Lexchin J, Bero L A, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1170
9. McCreadie R G, Scottish Schizophrenia Lifestyle Group (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 183: 534-539
10. Ryan M C, Collins P, Thakore J H (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160: 284-289
11. Thakore J H (2005) Metabolic syndrome and schizophrenia. Br J Psychiatry 186: 455-456.
12. Thakore J H, Mann J N, Vlahos I, Martin A, Reznek R (2002) Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 26: 137-141